UNIVLABS / GOMIDA

Translational research in urology.

Through Gomida, a UnivLabs subsidiary.

Turning everyday challenges in catheterisation and bladder care into practical medical-device solutions.

Gomida amSafeX catheter with its obturator and pull-ring components
amSafeXEngineering focused on catheter placement.

THE UROLOGY PORTFOLIO

Four areas. Practical clinical needs.

Explore what each product is designed to do, the evidence behind it and its current stage.

Gomida amSafeX catheter with obturator and pull-ring components

01 Catheter placement

amSafeX

An indwelling catheter designed to help verify balloon position inside the bladder during inflation.

Commercial in India · company-reported

Explore amSafeX
Gomida amSmart wearable urine collection product concept

Concept illustration — depicted capabilities require validation.

02 Wearable drainage

amSmart UroWear

Wearable urine collection with a connected variant designed for volume, flow and alerts.

Connected-care platform · availability to confirm

Explore amSmart UroWear
Gomida SupraSense sensor-enabled drainage concept

03 Pressure-aware care

SupraSense

A suprapubic drainage platform in development, designed to add bladder-pressure awareness to long-term care.

In development · final prototyping

Explore SupraSense
Gomida BiPS biodegradable prostate-stent design rendering

04 Biodegradable materials

BiPS

A biodegradable prostate-stent concept exploring temporary support for urine flow in benign prostatic obstruction.

In development · materials and evaluation planning

Explore BiPS

FROM CLINICAL NEED TO EVIDENCE

Research with a clear purpose.

Translational research connects a clinical problem to a device that can be built, tested and evaluated in care.

01

Start with the problem.

Placement uncertainty. The burden of drainage. Limited visibility of bladder behaviour. The need for temporary support.

02

Engineer a response.

Bring mechanical design, sensing and materials research together around a specific clinical use.

03

Test what matters.

Assess safety, usability and performance. Keep development aims separate from demonstrated clinical results.

125participants in the published
amSafeX study

Published research. Clearly stated limits.

The 2025 non-randomised study reported no urethral injuries during catheterisation in its participants. This does not establish zero risk or superiority.

Read the original study

Biodegradable-materials collaboration

A 2024 Government of India announcement describes IIT Roorkee–UnivLabs work on a biodegradable ureteral stent. This is distinct from the BiPS prostate-stent concept.

Read the official announcement

FOR CLINICIANS, HOSPITALS & RESEARCH PARTNERS

Bring us a clinical challenge.

Discuss product information, current availability, evaluation or research collaboration with our team.